The company behind Claude has filed to go public.
Anthropic has lodged the paperwork to sell shares on the stock market. Here is what that document actually is, what it does not yet say, and why the number everyone is quoting is not a price.
On 26 October, Anthropic filed an S-1 with America's financial regulator. It is the document a private company files when it wants to sell shares to the public, and it is the first time outsiders get to read the company's own account of how its business works.
Filing is not floating
The two get muddled constantly, so: filing is the application. Trading is the event. Between them sits a review by the regulator, a period where executives tour institutional investors to drum up interest, and the moment a price is finally set the night before.
Anthropic's filing is on record but not yet effective, which means no shares can change hands. Reporting points at a debut around the middle of November. Treat that as a plan, not a date — the company itself has left both the date and the price blank in its own document.
About that two trillion
You will have seen a figure of up to $2 trillion attached to this. It is worth understanding what such a number is and is not.
It is not a price anyone has paid. It is an estimate of what the whole company might be worth once shares trade, derived from what bankers think investors will bear. Until the shares open and people actually buy, it is a forecast wearing the clothes of a fact. Valuations quoted before an IPO move, sometimes a great deal, and sometimes downwards.
Why a company does this
Two reasons, mostly. It raises money — and training frontier models is among the most capital-hungry activities in modern business, as anyone who has read about data centres will recognise. And it gives early backers and employees a way to turn shares into cash, which is usually the quieter half of the motivation.
The cost is scrutiny. A public company files its numbers every quarter, in public, forever. For a laboratory that has made careful deliberation part of its identity, answering to shareholders who would like the line to go up every ninety days is a genuinely new pressure.
What the filing tells you that press releases do not
An S-1 contains a section called risk factors, where the company is legally obliged to write down everything that could go wrong. It is the least promotional prose a company ever produces, and consequently the most informative. If you read one part of any S-1, read that.
Can you buy it
Reporting suggests a slice — somewhere between fifteen and twenty per cent of the offering — may be set aside for ordinary investors through a bank, rather than the usual arrangement where institutions take nearly all of it at the offer price.
We are a magazine about how things work, not about what you should buy, and we are not going to tell you whether to. But know this much: shares bought on the first day of trading are bought at whatever the market decides that morning, which is frequently not the offer price, and the gap can go either way.
The thing worth watching
Not the opening pop. The filings afterwards. A company that has argued AI should be built carefully is about to start reporting to people who can sell their stake on a Tuesday because growth looked soft. Whether that changes anything about how the models get built is the actual story, and it will take years rather than days to read.